CSBR vs ROP · P/E 16, rev $56.9M vs P/E 41, rev $1.88B
Champions Oncology Inc (CSBR) versus Roper Technologies, Inc. (ROP) — a side-by-side from cached financials, not a winner call.
Champions Oncology Inc (CSBR) is a biotechnology company listed on US.
Roper Technologies, Inc. (ROP) is a software - application company listed on US.
Latest reported CSBR revenue for 2025-04-30 was $56.9M. Net income was $4.7M. CSBR currently screens at market cap $99.8M and trailing P/E 16.0.
Latest reported ROP revenue for 2024-12-31 was $1.88B. Net income was $462.3M. Revenue was up 6.4% from 2024-09-30 to 2024-12-31. ROP currently screens at market cap $61.61B and trailing P/E 41.3.
CSBR currently screens at market cap $99.8M and trailing P/E 16.0. ROP currently screens at market cap $61.61B and trailing P/E 41.3.
Not investment advice. Open the CSBR and ROP stock pages for the full models.
Not investment advice.